Resources

Download Library

Commitment to the Environment and Sustainability
Genmab R&D Update and ASH Data Review - December 2024
Articles of association dated December 3, 2024 – English
General Terms and Conditions of Purchase
Interim Report for the First Nine Months of 2024
Genmab First Nine Months 2024 Financial Results Presentation
Genmab Investor Presentation - November 2024
Genmab First Half 2024 Financial Results Presentation
Interim Report for the First Half of 2024
Genmab's Virtual mid- to late-stage pipeline update at ASCO 2024
Genmab Q1 2024 Financial Results Presentation
Interim Report for the First Quarter of 2024
Voting Results of the Annual General Meeting 2024
Genmab 2023 Full Year Financial Results Presentation
Corporate Governance Report 2023 - English
Genmab R&D Update and ASH Data Review - December 2023
Clinical Trial Transparency Declaration
Interim Report for the First Nine Months of 2023